Title:
FUSED HETEROCYCLIC COMPOUND, AND PREPARATION METHOD THEREFOR AND MEDICAL USE THEREOF
Document Type and Number:
WIPO Patent Application WO/2023/174374
Kind Code:
A1
Abstract:
The present disclosure relates to a fused heterocyclic compound, and a preparation method therefor and a medical use thereof. Specifically, the present disclosure relates to a fused heterocyclic compound shown in general formula (I), a preparation method for the compound, a pharmaceutical composition containing the compound, and a use of the compound as an RIPK1 kinase inhibitor, in particular a use in the preparation of a drug for treating and/or preventing RIPK1 kinase-mediated diseases or conditions.
More Like This:
| JP2002523414 | [Title of Invention] A novel compound |
| WO/1993/023391 | SUBSTITUTED INDOLES AND AZAINDOLES AS ANGIOTENSIN II ANTAGONISTS |
| WO/2015/100282 | TRICYCLIC COMPOUNDS AS ANTICANCER AGENTS |
Inventors:
ZHANG RUI (CN)
LI XIN (CN)
ZHANG JING (CN)
YUAN HUIQING (CN)
HE FENG (CN)
TAO WEIKANG (CN)
LI XIN (CN)
ZHANG JING (CN)
YUAN HUIQING (CN)
HE FENG (CN)
TAO WEIKANG (CN)
Application Number:
PCT/CN2023/081908
Publication Date:
September 21, 2023
Filing Date:
March 16, 2023
Export Citation:
Assignee:
JIANGSU HENGRUI PHARMACEUTICALS CO LTD (CN)
SHANGHAI HENGRUI PHARMACEUTICAL CO LTD (CN)
SHANGHAI HENGRUI PHARMACEUTICAL CO LTD (CN)
International Classes:
C07D471/04
Domestic Patent References:
| WO2003095625A2 | 2003-11-20 | |||
| WO2007095495A2 | 2007-08-23 | |||
| WO2019164941A1 | 2019-08-29 | |||
| WO2019164949A1 | 2019-08-29 |
Foreign References:
| CN113773316A | 2021-12-10 | |||
| CN1596114A | 2005-03-16 | |||
| CN103635467A | 2014-03-12 | |||
| US20180064726A1 | 2018-03-08 |
Attorney, Agent or Firm:
GE CHENG & CO., LTD. (CN)
Download PDF:
Previous Patent: PROCESS SCHEDULING METHOD, APPARATUS, AND DEVICE, AND MEDIUM
Next Patent: METHOD AND APPARATUS USED IN NODE FOR WIRELESS COMMUNICATION
Next Patent: METHOD AND APPARATUS USED IN NODE FOR WIRELESS COMMUNICATION